SCHEMBL29862249

SCHEMBL29862249

CCN(C)c1cccc2cccc(N(C)C)c12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.72
MAPT P10636 4/20 0.72
GAA P10253 3/20 0.72
MCL1 Q07820 1/20 0.38
ALDH1A1 P00352 4/20 0.37
SIGMAR1 Q99720 3/20 0.37
CYP1A2 P05177 2/20 0.37
HTR2A P28223 2/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
HIF1A Q16665 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 2/20 0.36
CYP1A1 P04798 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
CYP1B1 Q16678 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTR6 P50406 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N,N-Dimethylethanaminium SCHEMBL8487667 0.88 KDM4E (0.78) KDM4EMAPTGAAMCL1ALDH1A1
SCHEMBL17384923 0.86 KDM4E (0.52) KDM4EMAPTGAAALDH1A1SIGMAR1
SCHEMBL6285846 0.85 MAPT (1.00) KDM4EMAPTGAAMCL1ALDH1A1
SCHEMBL29363940 0.85 MAPT (1.00) KDM4EMAPTGAAMCL1ALDH1A1
SCHEMBL28279 0.85 MAPT (1.00) KDM4EMAPTGAAMCL1ALDH1A1
Ammonia Solution, Strong SCHEMBL6838810 0.83 MAPT (0.95) KDM4EMAPTGAAMCL1ALDH1A1
Ammonia Solution, Strong SCHEMBL9336609 0.83 MAPT (0.95) KDM4EMAPTGAAMCL1ALDH1A1
SCHEMBL30833304 0.83 MAPT (0.95) KDM4EMAPTGAAMCL1ALDH1A1
Hydrochloric Acid SCHEMBL9815129 0.83 MAPT (0.95) KDM4EMAPTGAAMCL1ALDH1A1
SCHEMBL29862047 0.82 KDM4E (0.62) KDM4EMAPTGAAMCL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 US disclosed
EP-4069806-B1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2025-04-16 EP disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 EP disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 US disclosed
EP-4069807-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS Sicpa Holding SA (CH) 2022-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 KDM4E 1686/4885MAPT 4817/4885GAA 4673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.